REGULATORY REQUIREMENTS & MARKETING AUTHORIZATION OF GENERIC DRUGS IN SINGAPORE & THAILAND
Abstract
The availability of generic medication is an important issue in the ASEAN region. The regulatory requirements of various countries vary from each other. Therefore, it is challenge for the companies to get drug approved for marketing simultaneously in different countries. The role of the regulatory authorities is to ensure the quality, safety, and efficacy of medicines in their country. It not only includes the process of regulating and monitoring the drugs, but also the process of manufacturing, distribution, and promotion. The regulatory environment has similar characteristics, but drug registration requirements and processes differ among the countries. One of the primary challenges for regulatory authority is to ensure that the pharmaceutical products are developed as per the regulatory requirement of that country. This process involves the assessment of critical parameters during product development. In ASEAN region, documentation can be filed in the ACTD format. Even though ACTD format is mandatory from 2009, the member countries have their own requirements for registration process like administrative documents, labeling. The purpose of this paper is to give a comparative overview on the Drug regulatory requirement for generics in two of the ASEAN countries which are Singapore and Thailand.
Downloads
References
http://www.asean.org/communities/asean-economic-community/item/accsq-pharmaceutical-product-working-group
2. Wikipedia - Association of Southeast Asian Nations [Internet]. Wikipedia; 2015 [2015 March 13] [cited 2015 Jan 12]. Available from:
http://en.wikipedia.org/wiki/Association_of_Southeast_Asian_Nations
3. ICH [Internet]. ASEAN PPWG [date unknown] [cited 2014 Jan 09]. Available from: http://www.ich.org/about/organisation-of-ich/coopgroup/asean.html
4. The ASEAN Common Technical Document (ACTD) for the registration of pharmaceuticals for human use. Organization of the dossier [Internet]. HSA.GOV [date unknown] [cited 2014 Dec 09]. Available from:
http://www.hsa.gov.sg/content/dam/HSA/HPRG/Western_Medicine/Overview_Framework_Policies/Guidelines_on_Drug_Registration/ACTD_OrganizationofDossier.pdf
5. Guidance on Medicinal Product Registration, Health Sciences Authority, Singapore [Internet]. HSA.GOV; 2011 [date unknown] [cited 2014 Nov 29]. Available from:
http://www.hsa.gov.sg/content/dam/HSA/HPRG/Western_Medicine/Overview_Framework_Policies/Guidelines_on_Drug_Registration/Guidance%20on%20Medicinal%20Product%20Registration%20in%20Singapore%202011%20(COMPLETE).pdf
6. Food and Drug Administration, Thailand [Internet]. FDA; 2004 Oct [cited 2014 Dec 13]. Available from: http://www.fda.moph.go.th/eng/drug/intro.stm
7. Food and Drug Administration, Thailand, Drug control division. Available at[Internet]. FDA; 2004 Oct [cited 2014 Dec 13]. Available from:
http://www.fda.moph.go.th/eng/drug/index.stm
8. Gross A. New Regulatory Trends In Thailand's Pharmaceutical Market. [Internet]. Pacific Bridge Medical; 1999 March 1 [cited 2014 Nov 11].
Available from:
http://www.pacificbridgemedical.com/publications/new-regulatory-trends-in-thailand-s-pharma ceutical-market/
9. Russell P. et al. Thailand Regulatory Overview: Life Sciences Handbook [Internet]. Practical Law Company; 2011 [cited 2014 Nov 10].
Available from tilleke:
http://www.tilleke.com/sites/default/files/2011_PLC_Life_Science_Thailand.pdf
10. Drug Control and Registration; Siriporn Chawanon, Drug Control Division, Thai Food and Drug Administration. [Internet]. Thai Food and Drug Administration [date unknown] [cited 2014 Nov 11]. Available from: http://www.conceptfoundation.org/files/meeting/14.%20Chawanon%20%20Drug%20Registration%20Thailand.pdf
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
